Quick Takeaways: Why It Matters? Full approval and label expansion make Vetmedin the standard of care for early-stage MMVD, locking in pimobendan as the only FDA‑approved option for delaying CHF in Stage B2 dogs and driving guideline‑aligned, earli...
Quick Takeaways: Why It Matters? With both TAS and RXE accepted, Loyal moves significantly closer to commercializing the first true longevity drug in veterinary medicine, turning canine lifespan extension into a near-term, rather than speculative, market. If LOY-002 reache...
Dechra Secures FDA Approval for Zygolide (Pergolide) in Equine Pituitary Pars Intermedia Dysfunction
Quick Takeaways: Why It Matters? Zygolide gives vets and owners a lower-cost, FDA-approved alternative for managing PPID, which should improve treatment uptake in senior horses. The focus on flexible dosing and palatability makes long-term therapy more practical in th...
Rank Companies Animal Health Revenue (2023 $M) Animal Health Revenue (2024 $M) Percent change (%) 1 Zoetis 8,544 9,256 8.33 2 MSD Animal Health 5,625 5,877 4.48 3 BI Animal Health 5,213.60...
20. ImmuCell Revenue: $17.47M Founded Year: 1987 Market Cap: Total Employees: ~100 Headquarters: Portland, United States Stock Exchange: NASDAQ 19. Hester Biosciences Revenue: $33.24M Founded Year: 1987 Market Cap: Total Employees: ~600 Headquarters: Gujrat, India Stock Exchange: NSE 18. V...
20. ImmuCell Revenue: $18.6M Founded Year: 1982 Market Cap: $35.11M Total Employees: ~70 Headquarters: Maine, United States Stock Exchange: NASDAQ 19. Hester Pharmaceuticals & Biotech Revenue: $32M Founded Year: 1987 Market Cap: $150.13 Tota...
